NTRA
NASDAQ · Biotechnology
Natera Inc
$196.15
-1.22 (-0.62%)
Performance
1D
—
1W
—
1M
—
3M
-15.20%
6M
+20.27%
1Y
+32.27%
YTD
-14.29%
Open$195.36
Previous Close$197.37
Day High$198.52
Day Low$194.56
52W High$256.36
52W Low$125.38
Volume—
Avg Volume1.30M
Market Cap27.94B
P/E Ratio—
EPS$-1.53
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$229.31
Below
SMA 200
$186.42
Above
RSI (14)
38.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-27.1% upside
Current
$196.15
$196.15
Target
$142.91
$142.91
$88.14
$142.91 avg
$188.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.38B | 1.69B | 5.13B |
| Net Income | -214,707,602 | -136,911,465 | 875.75M |
| Profit Margin | -9.0% | -8.6% | 17.1% |
| EBITDA | -317,894,171 | -213,971,561 | 1.33B |
| Free Cash Flow | — | — | 778.23M |
| Rev Growth | +41.1% | +41.1% | +14.5% |
| Debt/Equity | 0.05 | 0.05 | 1.21 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $211.12 | +1.90% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.16 | -0.22% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $136.88 | -1.00% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $453.74 | -0.27% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $756.73 | +0.97% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.16% | 139.7 | 43.84B |